HEALTH● LOWSep 9 · Sep 9, 2026, 2:17 PM
Semaglutide Tied to 21% Fewer Psychiatric Stays in Bipolar Swedes
Human Progress · western europe
“Semaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization.” From ScienceDaily. The post Semaglutide Tied to Psychiatric Benefits for Bipolar Swedes appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH8m agoPope Leo 'slept well' as his recovery continues, Vatican saysABC NewsHEALTH2h ago161 confirmed measles cases, one death reported in KozhikodeThe HinduHEALTH4h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH4h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]